Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARVARD BIOSCIENCE INC Director's Dealing 2008

Nov 18, 2008

34975_dirs_2008-11-18_a6c7284a-178b-491f-9dfe-8342788e7306.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2008-11-14

Reporting Person: McNaughton Thomas (Chief Financial Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2008-11-14 Incentive Stock Option (right to buy) $2.82 A 100000 Acquired 2018-11-14 Common Stock, par value $0.01 per share (100000) Direct

Footnotes

F1: Shares vest in four equal installments on September 16, 2009, 2010, 2011 and 2012.